A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease
Clinical trial NCT00256204 · COMPLETED
Trial details
- NCT number
- NCT00256204
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2008-04-01
- Enrollment
- 1174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.